These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38296726)

  • 1. Retraction notice to "LncRNA SNHG16 promotes tumor growth of pancreatic cancer by targeting miR-218-5p" [Biomed. Pharmacother. 114 (2019) 108862].
    Liu S; Zhang W; Liu K; Liu Y
    Biomed Pharmacother; 2024 Feb; 171():116188. PubMed ID: 38296726
    [No Abstract]   [Full Text] [Related]  

  • 2. Retraction notice to "Long noncoding RNA SNHG16 promotes human retinoblastoma progression via sponging miR-140-5p" [Biomed. Pharmacother. 117 (2019) 109153].
    Xu C; Hu C; Wang Y; Liu S
    Biomed Pharmacother; 2022 Jun; 150():112857. PubMed ID: 35341639
    [No Abstract]   [Full Text] [Related]  

  • 3. Retraction notice to: "LncRNA SNHG3 promotes the growth and metastasis of colorectal cancer by regulating miR-539/RUNX2 axis" Biomed. Pharmacother. 125 (2020) 110039.
    Wen D; Li S; Jiang W; Zhao S; Liu J; Zhu J
    Biomed Pharmacother; 2023 Oct; 166():114877. PubMed ID: 37353385
    [No Abstract]   [Full Text] [Related]  

  • 4. Retraction notice to: "LncRNA DANCR silence inhibits SOX5-medicated progression and autophagy in osteosarcoma via regulating miR-216a-5p" [Biomed. Pharmacother. 122 (2019) 109707].
    Pan Z; Wu C; Li Y; Li H; An Y; Wang G; Dai J; Wang Q
    Biomed Pharmacother; 2023 Oct; 166():114876. PubMed ID: 37353384
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "LNCRNA CDKN2B-AS1 regulates mesangial cell proliferation and extracellular matrix accumulation via miR-424-5p/HMGA2 axis" [Biomed. Pharmacother. 121 (2020) 109622].
    Li Y; Zheng LL; Huang DG; Cao H; Gao YH; Fan ZC
    Biomed Pharmacother; 2023 Aug; 164():114728. PubMed ID: 37087341
    [No Abstract]   [Full Text] [Related]  

  • 6. LncRNA SNHG16 promotes tumor growth of pancreatic cancer by targeting miR-218-5p.
    Liu S; Zhang W; Liu K; Liu Y
    Biomed Pharmacother; 2019 Jun; 114():108862. PubMed ID: 30981105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction notice to "lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer" [Biomed. Pharmacother. 114 (2019) 108814].
    Jiang F; Qi W; Wang Y; Wang W; Fan L
    Biomed Pharmacother; 2022 Jan; 145():112511. PubMed ID: 34895810
    [No Abstract]   [Full Text] [Related]  

  • 8. Retraction notice to "Long non-coding RNA HULC interacts with miR-613 to regulate colon cancer growth and metastasis through targeting RTKN" [Biomed. Pharmacother. 109 (2019) 2035-2042].
    Dong Y; Wei MH; Lu JG; Bi CY
    Biomed Pharmacother; 2023 Nov; 167():115370. PubMed ID: 37802725
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraction notice to "Long non-coding RNA TTN-AS1 promotes tumorigenesis of ovarian cancer through modulating the miR-139-5p/ROCK2 axis" [Biomed. Pharmacother. 125 (2020) 109882].
    Liu X; Li Y; Wen J; Qi T; Wang Y
    Biomed Pharmacother; 2022 Sep; 153():113356. PubMed ID: 35835667
    [No Abstract]   [Full Text] [Related]  

  • 10. Silencing of LncRNA SNHG16 Downregulates Cyclin D1 (CCND1) to Abrogate Malignant Phenotypes in Oral Squamous Cell Carcinoma (OSCC) Through Upregulating miR-17-5p.
    Wang Q; Han J; Xu P; Jian X; Huang X; Liu D
    Cancer Manag Res; 2021; 13():1831-1841. PubMed ID: 33654431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction notice to "LncRNA DICER1-AS1 promotes the proliferation, invasion and autophagy of osteosarcoma cells via miR-30b/ATG5" [Biomed. Pharmacother., 104 (2018) 110-118].
    Gu Z; Hou Z; Zheng L; Wang X; Wu L; Zhang C
    Biomed Pharmacother; 2024 Mar; 172():116198. PubMed ID: 38296734
    [No Abstract]   [Full Text] [Related]  

  • 12. LncRNA SNHG16 Knockdown Promotes Diabetic Foot Ulcer Wound Healing via Sponging MiR-31-5p.
    Chen L; Shen S; Wang S
    Tohoku J Exp Med; 2023 Dec; 261(4):283-289. PubMed ID: 37704416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG16 Promotes the Progression of Laryngeal Squamous Cell Carcinoma by Mediating miR-877-5p/FOXP4 Axis.
    Wang X; Liu L; Zhao W; Li Q; Wang G; Li H
    Onco Targets Ther; 2020; 13():4569-4579. PubMed ID: 32547087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retraction notice to "MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC)" [Biomed. Pharmacother. 76 (2015) 82-93].
    Mao Y; Liu J; Zhang D; Li B
    Biomed Pharmacother; 2024 Feb; 171():116189. PubMed ID: 38296731
    [No Abstract]   [Full Text] [Related]  

  • 15. Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p/PIM1 axis.
    Zhu Q; Li Y; Guo Y; Hu L; Xiao Z; Liu X; Wang J; Xu Q; Tong X
    J Cell Mol Med; 2019 Nov; 23(11):7395-7405. PubMed ID: 31483572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SNHG16 promotes proliferation and migration in laryngeal squamous cell carcinoma via the miR-140-5p/NFAT5/Wnt/β-catenin pathway axis.
    Wan L; Gu D; Li P
    Pathol Res Pract; 2022 Jan; 229():153727. PubMed ID: 34911016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction notice to "Long non-coding RNA LINC00525 promotes the non-small cell lung cancer progression by targeting miR-338-3p/IRS2 axis" [Biomed. Pharmacother. 124 (2020) 109858].
    Yang Z; Lin X; Zhang P; Liu Y; Liu Z; Qian B; Liu X; Shao G
    Biomed Pharmacother; 2023 Apr; 160():114278. PubMed ID: 36732173
    [No Abstract]   [Full Text] [Related]  

  • 18. LncRNA SNHG16 promotes Schwann cell proliferation and migration to repair sciatic nerve injury.
    Chen Y; Fan Z; Dong Q
    Ann Transl Med; 2021 Aug; 9(16):1349. PubMed ID: 34532486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retraction notice to "Knockdown of lncRNA XIST inhibits retinoblastoma progression by modulating the miR-124/STAT3 axis" [Biomed. Pharmacother. 107(2018) 547-554].
    Hu C; Liu S; Han M; Wang Y; Xu C
    Biomed Pharmacother; 2022 May; 149():112795. PubMed ID: 35282972
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel lncRNA SNHG16 Promotes the Growth and Metastasis of Malignant Melanoma by Regulating miR-205-5p/PAK2 Axis.
    Xia Y; Guan J; Lu X; Liu Y; Luan W
    Clin Cosmet Investig Dermatol; 2022; 15():1615-1625. PubMed ID: 35983126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.